# Inuvo, Inc.: financial statements, quarterly

INUV · NYSE · CIK 829323 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/inuv.md) · [Financials](/companies/inuv/financials.md) · [Filings](/companies/inuv/filings.md) · [Insiders](/companies/inuv/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/inuv/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [24.6](/filings/0001654954-24-013975.md) | [20.8 d](/filings/0001654954-25-002032.md) | [17.0](/filings/0001654954-25-005321.md) | [18.2](/filings/0001654954-25-009219.md) | [22.4](/filings/0001654954-25-012670.md) | [26.2 d](/filings/0001654954-26-001943.md) | [26.7](/filings/0001654954-26-004909.md) | [22.7](/filings/0001654954-26-007480.md) | [22.6](/filings/0001654954-25-012670.md) | [14.3 d](/filings/0001654954-26-001943.md) | [7.9](/filings/0001654954-26-004909.md) | [7.5](/filings/0001654954-26-007480.md) |
| Cost of revenue | $m | [2.3](/filings/0001654954-24-013975.md) | [2.6 d](/filings/0001654954-25-002032.md) | [2.1](/filings/0001654954-25-005321.md) | [2.9](/filings/0001654954-25-009219.md) | [2.6](/filings/0001654954-25-012670.md) | [4.4 d](/filings/0001654954-26-001943.md) | [5.6](/filings/0001654954-26-004909.md) | [5.6](/filings/0001654954-26-007480.md) | [6.0](/filings/0001654954-25-012670.md) | [4.8 d](/filings/0001654954-26-001943.md) | [4.3](/filings/0001654954-26-004909.md) | [4.2](/filings/0001654954-26-007480.md) |
| Gross profit | $m | [22.3](/filings/0001654954-24-013975.md) | [18.2 d](/filings/0001654954-25-002032.md) | [14.9](/filings/0001654954-25-005321.md) | [15.3](/filings/0001654954-25-009219.md) | [19.8](/filings/0001654954-25-012670.md) | [21.8 d](/filings/0001654954-26-001943.md) | [21.1](/filings/0001654954-26-004909.md) | [17.1](/filings/0001654954-26-007480.md) | [16.6](/filings/0001654954-25-012670.md) | [9.5 d](/filings/0001654954-26-001943.md) | [3.7](/filings/0001654954-26-004909.md) | [3.3](/filings/0001654954-26-007480.md) |
| Selling, general and administrative | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [(1.2)](/filings/0001654954-24-013975.md) | [(2.4) d](/filings/0001654954-25-002032.md) | [(2.1)](/filings/0001654954-25-005321.md) | [(1.7)](/filings/0001654954-25-009219.md) | [(1.9)](/filings/0001654954-25-012670.md) | [0.2 d](/filings/0001654954-26-001943.md) | [(1.8)](/filings/0001654954-26-004909.md) | [(2.0)](/filings/0001654954-26-007480.md) | [(1.7)](/filings/0001654954-25-012670.md) | [(1.2) d](/filings/0001654954-26-001943.md) | [(3.9)](/filings/0001654954-26-004909.md) | [(3.0)](/filings/0001654954-26-007480.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.0](/filings/0001654954-24-013975.md) | [(0.0) d](/filings/0001654954-25-002032.md) | [0.0](/filings/0001654954-25-005321.md) | [0.0](/filings/0001654954-25-009219.md) | [0.0](/filings/0001654954-25-012670.md) | [0.0 d](/filings/0001654954-26-001943.md) | [0.0](/filings/0001654954-26-004909.md) | [0.0](/filings/0001654954-26-007480.md) | [0.0](/filings/0001654954-25-012670.md) | [0.0 d](/filings/0001654954-26-001943.md) | [0.0](/filings/0001654954-26-004909.md) | [0.0](/filings/0001654954-26-007480.md) |
| Net income | $m | [(1.2)](/filings/0001654954-24-013975.md) | [(2.4) d](/filings/0001654954-25-002032.md) | [(2.1)](/filings/0001654954-25-012670.md) | [(1.7)](/filings/0001654954-25-012670.md) | [(2.0)](/filings/0001654954-25-012670.md) | [0.1 d](/filings/0001654954-26-001943.md) | [(1.3)](/filings/0001654954-26-007480.md) | [(1.5)](/filings/0001654954-26-007480.md) | [(1.7)](/filings/0001654954-25-012670.md) | [(0.6) d](/filings/0001654954-26-001943.md) | [1.9](/filings/0001654954-26-007480.md) | [(4.0)](/filings/0001654954-26-007480.md) |
| Diluted EPS | $ per share | [(0.01)](/filings/0001654954-24-013975.md) | not reported | [(0.02)](/filings/0001654954-25-005321.md) | [(0.01)](/filings/0001654954-24-010179.md) | [(0.15)](/filings/0001654954-25-012670.md) | not reported | [(0.09)](/filings/0001654954-26-004909.md) | [(0.10)](/filings/0001654954-26-007480.md) | [(0.12)](/filings/0001654954-25-012670.md) | not reported | [0.13](/filings/0001654954-26-004909.md) | [(0.27)](/filings/0001654954-26-007480.md) |
| Basic EPS | $ per share | [(0.01)](/filings/0000829323-23-000031.md) | not reported | not reported | [(0.12)](/filings/0001654954-25-009219.md) | not reported | not reported | [(0.09)](/filings/0001654954-26-004909.md) | [(0.10)](/filings/0001654954-26-007480.md) | not reported | not reported | [0.13](/filings/0001654954-26-004909.md) | [(0.27)](/filings/0001654954-26-007480.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax, us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold, us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [7.0](/filings/0000829323-23-000031.md) | not reported | [2.0](/filings/0001654954-24-005713.md) | not reported | not reported | not reported | not reported | not reported | not reported | [2.8](/filings/0001654954-26-007480.md) | not reported | [0.9](/filings/0001654954-26-007480.md) |
| Current assets | $m | [18.1](/filings/0000829323-23-000031.md) | [14.7](/filings/0001654954-25-002032.md) | [12.2](/filings/0001654954-24-005713.md) | [11.1](/filings/0001654954-24-010179.md) | [12.3](/filings/0001654954-24-013975.md) | [15.6](/filings/0001654954-26-001943.md) | [15.3](/filings/0001654954-25-005321.md) | [12.5](/filings/0001654954-25-009219.md) | [14.0](/filings/0001654954-25-012670.md) | [9.2](/filings/0001654954-26-007480.md) | [7.8](/filings/0001654954-26-004909.md) | [7.3](/filings/0001654954-26-007480.md) |
| Total assets | $m | [36.2](/filings/0000829323-23-000031.md) | [32.4](/filings/0001654954-25-002032.md) | [29.8](/filings/0001654954-24-005713.md) | [28.5](/filings/0001654954-24-010179.md) | [29.0](/filings/0001654954-24-013975.md) | [32.2](/filings/0001654954-26-001943.md) | [31.7](/filings/0001654954-25-005321.md) | [28.7](/filings/0001654954-25-009219.md) | [29.9](/filings/0001654954-25-012670.md) | [24.9](/filings/0001654954-26-007480.md) | [23.2](/filings/0001654954-26-004909.md) | [27.3](/filings/0001654954-26-007480.md) |
| Current liabilities | $m | [16.4](/filings/0000829323-23-000031.md) | [14.5](/filings/0001654954-25-002032.md) | [13.6](/filings/0001654954-24-005713.md) | [13.9](/filings/0001654954-24-010179.md) | [15.7](/filings/0001654954-24-013975.md) | [17.9](/filings/0001654954-26-001943.md) | [17.5](/filings/0001654954-25-005321.md) | [15.9](/filings/0001654954-25-009219.md) | [18.9](/filings/0001654954-25-012670.md) | [14.3](/filings/0001654954-26-007480.md) | [10.6](/filings/0001654954-26-004909.md) | [12.1](/filings/0001654954-26-007480.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [18.9](/filings/0001654954-24-013975.md) | [17.0](/filings/0001654954-26-001943.md) | [15.1](/filings/0001654954-25-012670.md) | [13.5](/filings/0001654954-25-012670.md) | [12.4](/filings/0001654954-25-012670.md) | [13.5](/filings/0001654954-26-007480.md) | [13.4](/filings/0001654954-26-007480.md) | [12.1](/filings/0001654954-26-007480.md) | [10.4](/filings/0001654954-25-012670.md) | [10.0](/filings/0001654954-26-007480.md) | [12.2](/filings/0001654954-26-007480.md) | [8.3](/filings/0001654954-26-007480.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: not reported
- Long-term debt: not reported
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [2,376 d](/filings/0001654954-24-013975.md) | [(2,096) d](/filings/0001654954-25-002032.md) | [(1,356)](/filings/0001654954-25-005321.md) | [195 d](/filings/0001654954-25-009219.md) | [1,060 d](/filings/0001654954-25-012670.md) | [330 d](/filings/0001654954-26-001943.md) | [(367)](/filings/0001654954-26-004909.md) | [144 d](/filings/0001654954-26-007480.md) | [(1,584) d](/filings/0001654954-25-012670.md) | [21.0 d](/filings/0001654954-26-001943.md) | [1,590](/filings/0001654954-26-004909.md) | [(2,307) d](/filings/0001654954-26-007480.md) |
| Capital expenditure | $k | [423 d](/filings/0001654954-24-013975.md) | [423 d](/filings/0001654954-25-002032.md) | [472](/filings/0001654954-25-005321.md) | [462 d](/filings/0001654954-25-009219.md) | [476 d](/filings/0001654954-25-012670.md) | [448 d](/filings/0001654954-26-001943.md) | [452](/filings/0001654954-26-004909.md) | [407 d](/filings/0001654954-26-007480.md) | [383 d](/filings/0001654954-25-012670.md) | [361 d](/filings/0001654954-26-001943.md) | [359](/filings/0001654954-26-004909.md) | [239 d](/filings/0001654954-26-007480.md) |
| Share repurchases | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [120](/filings/0000829323-23-000031.md) | [121](/filings/0001654954-24-005713.md) | [127](/filings/0001654954-24-010179.md) | [127](/filings/0001654954-24-013975.md) | [139](/filings/0001654954-25-005321.md) | [14.0](/filings/0001654954-25-009219.md) | [14.0](/filings/0001654954-25-012670.md) | [14.3](/filings/0001654954-26-004909.md) | [14.5](/filings/0001654954-26-007480.md) | [14.6](/filings/0001654954-25-012670.md) | [14.9](/filings/0001654954-26-004909.md) | [14.8](/filings/0001654954-26-007480.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 16,483,079 at 2026-08-03, from the cover of the [10-Q filed 2026-08-11](/filings/0001654954-26-007480.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:25 ET. No prices; not investment advice.